<PAGE>
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statements on
Form S-8 (No. 333-35919) pertaining to the Cell Therapeutics, Inc. 1994 Equity
Incentive Plan and the Cell Therapeutics, Inc. 1996 Employee Stock Purchase
Plan, Forms S-3 (Nos. 333-93835, 333-33268, 333-033872), and related
Prospectuses of our report dated February 25, 2000 with respect to the
consolidated financial statements of Cell Therapeutics, Inc. included in its
Annual Report (Form 10-K/A-2) for the year ended December 31, 1999 filed with
the Securities and Exchange Commission.
Ernst & Young LLP
Seattle, Washington
September 8, 2000
